Nonsteroidal Anti-inflammatory Drugs (NSAID) Market Report 2025-2031: Key Players & Insights

Q: Which region dominated the nonsteroidal anti-inflammatory drugs (NSAID) market in 2024?

North America dominated the market in 2024... Read more

Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Drug Class (Nonselective NSAIDs and COX-2 Selective NSAIDs), Route Of Administration (Oral, Injectable, and Topical), Indication (Arthritis, Migraine, Ophthalmic Diseases, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Channels), and Geography

Report Date : Aug 2025
Report Code : TIPRE00004421

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 273

The Nonsteroidal Anti-inflammatory Drugs (NSAID) market size is projected to reach US$ 38.38 billion by 2031 from US$ 24.82 billion in 2024. The market is expected to register a CAGR of 6.5% during 2025–2031.

Nonsteroidal Anti-inflammatory Drugs (NSAID) Market Analysis

The surging prevalence of chronic pain disorders and inflammatory conditions such as arthritis and headaches, and the growing adoption of non-opioid NSAIDs, are propelling the growth of the nonsteroidal anti-inflammatory drugs (NSAID) market. The introduction of NSAIDs offers an efficient approach for the treatment of pain and inflammation. In response to the growing burden of chronic pain, pharmaceutical companies are introducing new NSAID formulations to meet patient needs.

The increasing strategic initiatives by manufacturers of NSAIDs present a significant market opportunity. They are a major factor contributing to the growth of nonsteroidal anti-inflammatory drugs (NSAIDs).

Nonsteroidal Anti-inflammatory Drugs (NSAID) Market Overview

The global market for Nonsteroidal Anti-Inflammatory Drugs is expected to grow steadily in the coming years. An increase in chronic pain, inflammatory disorders, and an aging population fuels this growth.

NSAIDs can be classified by their chemical structure and their selectivity for COX enzymes. Some are nonselective, affecting both COX-1 and COX-2, while others are selective for COX-2. These drugs are a group of medications that reduce pain, fever, and inflammation. They commonly treat conditions such as arthritis, muscle pain, and menstrual cramps.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market: Strategic Insights

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst

Nonsteroidal Anti-inflammatory Drugs (NSAID) Market Drivers and Opportunities

Market Drivers:

Expanding Preference for NSAIDs as Non-Opioid Pain Management:
NSAIDs are increasingly recognized for effectively alleviating pain while reducing the risk of dependency and side effects commonly linked to opioids. As a result, more patients and providers are turning to these medications to address pain more safely and sustainably.
Increasing Prevalence Of Chronic and Inflammatory Diseases:
The introduction of NSAIDs offers an efficient approach for the treatment of pain and inflammation-causing disorders such as headaches, osteoarthritis, muscle and joint injuries, and various neuropathies.
Rising Aging Population:
Aging populations in countries such as Japan, China, and South Korea contribute further, as elderly individuals are more prone to these ailments.

Market Opportunities:

Expansion in Emerging Economies:
Several countries in Asia Pacific, Latin America, and Africa offer growth opportunities in the nonsteroidal anti-inflammatory drugs (NSAID) market due to the increasing number of chronic infections and adoption of non-opioid pain management.
Rising Strategic Initiatives:
Increasing organic and inorganic initiatives, such as new product launches and geographical expansion by market players, offer lucrative opportunities for market size expansion.

Nonsteroidal Anti-inflammatory Drugs (NSAID) Market Report Segmentation Analysis

The nonsteroidal anti-inflammatory drugs (NSAID) market is divided into different segments to give a clearer view of how it works, its growth potential, and the latest trends. Below is the standard segmentation approach used in most industry reports:

By Drug Class:

Nonselective NSAIDs:
Nonselective COX-2 inhibitors, including ibuprofen and naproxen, effectively reduce pain and inflammation by inhibiting both COX-1 and COX-2 enzymes. These drugs are increasingly in demand due to their broad-spectrum anti-inflammatory and analgesic effects.
COX-2 Selective NSAIDs:
Selective COX-2 inhibitors, such as celecoxib (Celebrex) and etoricoxib, are designed to specifically block the enzyme cyclooxygenase-2 (COX-2), which is primarily responsible for producing prostaglandins that cause pain, inflammation, and fever during tissue injury.

By Route Of Administration:

Oral:
Oral NSAIDs can offer consistent systemic effects necessary for addressing widespread inflammation. Their efficacy, ease of use, and broad availability contribute to their increasing popularity.
Injectable:
Injectable NSAIDs allow for shorter hospital stays and improved patient satisfaction by providing effective pain control early after surgery or trauma.
Topical:
Patients and clinicians prefer topical NSAIDs to reduce systemic exposure and adverse events. Regulatory approvals of topical diclofenac formulations—such as gel 1%, patch 1.3%, and solution 1.5%—support this trend.

By Route Of Administration:

Arthritis
Migraine
Ophthalmic Diseases
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Channels

By Geography:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

The nonsteroidal anti-inflammatory drugs (NSAID) market in North America is expected to hold a significant share of the market.

Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Report ScopeNonsteroidal Anti-inflammatory Drugs (NSAID) Market Share Analysis by Geography

Asia Pacific is expected to grow the fastest in the next few years. Emerging economies such as Latin America, the Middle East, and Africa also have many untapped opportunities for nonsteroidal anti-inflammatory drug providers to expand.

The nonsteroidal anti-inflammatory drugs (NSAID) market grows differently in each region. This is because of factors including surging prevalence of inflammatory diseases, a growing aging population, and increasing business development initiatives by the market players. Below is a summary of market share and trends by region:

1. North America

Market Share:
Holds a significant portion of the global market
Key Drivers:
- Rise in musculoskeletal disorders, including arthritis.
- Increased awareness of the adverse effects of opioid painkillers
Trends:
Shift toward safer NSAID formulations with better gastrointestinal (GI) and cardiovascular profiles.

2. Europe

Market Share:
Substantial share due to the adoption of OTC NSAIDs.
Key Drivers:
- Government support and favorable reimbursement policies.
- Growing awareness of migraines and other pain conditions.
Trends:
Technological advancements in drug delivery systems.

3. Asia Pacific

Market Share:
Fastest-growing region with a rising market share every year
Key Drivers:
- Increasing aging population.
- Growing demand for OTC NSAIDs
- Increasing disposable income
Trends:
Rise in medical tourism

4. South and Central America

Market Share:
Growing market with steady progress
Key Drivers:
- Expanding access to healthcare services, particularly in urban areas
- Availability of essential drugs at subsidized rates
Trends:
Rise in medical tourism

5. Middle East and Africa

Market Share:
Although small, it is growing quickly
Key Drivers:
- Expanding Healthcare infrastructure
- Rising awareness about hygiene and infection control in healthcare settings
Trends:
Government initiatives supporting healthcare infrastructure.

Nonsteroidal Anti-inflammatory Drugs (NSAID) Market Players Density: Understanding Its Impact on Business Dynamics

High Market Density and Competition

Competition is strong due to the presence of established players such as Boehringer Ingelheim International GmbH, Hikma, and Novartis AG. Regional and niche providers like Pfizer (Asia Pacific) and Dr. Reddy's Laboratories Ltd (Asia Pacific) also add to the competitive landscape across different regions.

This high level of competition urges companies to stand out by offering:

Advanced Products
Value-added services like customization and sustainable solutions
Competitive pricing models
Compliance with regulatory guidelines

Opportunities and Strategic Moves

Focusing on specialized gloves for sectors such as medical, food processing, industrial, and laboratory, featuring antimicrobial coatings and smart sensors for health monitoring.
Companies are moving towards biodegradable and recyclable glove products to address regulatory and consumer concerns about plastic waste and environmental impact.
Focusing on direct-to-consumer channels and enhancing the use of e-commerce platforms to reach a wider range of customer segments.

Major Companies operating in the Nonsteroidal Anti-inflammatory Drugs (NSAID) Market are:

Pfizer
Bayer AG
Glenmark Pharmaceuticals Ltd.
Dr. Reddy's Laboratories Ltd
Boehringer Ingelheim International GmbH
Haleon plc
Sun Pharmaceutical Industries Ltd
Novartis AG
Hikma Pharmaceuticals
Viatris Inc.

Disclaimer: The companies listed above are not ranked in any particular order.

Other companies analysed during the course of research:

Teva Pharmaceutical Industries
Mylan
Aurobindo Pharma
Actavis
Wuxi AppTec
Zhejiang NHU
Johnson & Johnson (McNeil)
Sanofi
Reckitt Benckiser Group
Horizon Therapeutics
Assertio Holdings
Perrigo Company
AbbVie
Endo International
Orion Corporation
Strides Pharma Science Limited

Nonsteroidal Anti-inflammatory Drugs (NSAID) Market News and Recent Developments

Boehringer Ingelheim BioXcellence is expanding its service portfolio in China
Boehringer Ingelheim's biopharmaceutical facility in Shanghai, China, meets the conditions required to participate in a regulatory reform promoting the segmented manufacturing of biological products by the local authorities.

Hikma Pharmaceuticals PLC (Hikma) launched Indomethacin suppositories in the US.
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, launched Indomethacin Suppositories in the US in a 50mg dose. This product has been approved for marketing in the United States by the US FDA.

Nonsteroidal Anti-inflammatory Drugs (NSAID) Market Report Coverage and Deliverables

The "Nonsteroidal Anti-inflammatory Drugs (NSAID) Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

Nonsteroidal Anti-inflammatory Drugs (NSAID) Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Nonsteroidal Anti-inflammatory Drugs (NSAID) Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST and SWOT analysis
Nonsteroidal Anti-inflammatory Drugs (NSAID) Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Nonsteroidal Anti-inflammatory Drugs (NSAID) Market
Detailed company profiles

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

This text is related
to segments covered.

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

This text is related
to country scope.

Frequently Asked Questions

Which region dominated the nonsteroidal anti-inflammatory drugs (NSAID) market in 2024?

North America dominated the market in 2024.

What is the expected CAGR of the nonsteroidal anti-inflammatory drugs (NSAID) market?

The nonsteroidal anti-inflammatory drugs (NSAID) market is estimated to register a CAGR of 6.5% during the forecast period.

What would be the estimated value of the nonsteroidal anti-inflammatory drugs (NSAID) market by 2031?

The nonsteroidal anti-inflammatory drugs (NSAID) market is estimated to reach US$38.38 billion by 2031.

What are the factors driving the nonsteroidal anti-inflammatory drugs (NSAID) market?

The prevalence of chronic pain and inflammatory disorders, and growing inclination towards NSAIDs as the primary choice for non-opioid pain management are among the noteworthy factors contributing to the market growth.

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macro-economic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country level data:

3.3 Assumptions and Limitations

4. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Landscape

4.1 PEST Analysis

5. Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Key Market Dynamics

5.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Key Market Dynamics

5.2 Market Drivers

5.2.1 Rising Prevalence of Chronic Pain Disorders and Inflammatory Diseases

5.2.2 Shifting Preference for NSAIDs as Non-Opioid Pain Management

5.3 Market Restraints

5.3.1 Regulatory and Development Barriers

5.4 Market Opportunities

5.4.1 Strategic Initiatives by Market Players

5.5 Future Trends

5.5.1 Personalized and Precision Medicine Approaches in NSAIDs Use

5.6 Impact of Drivers and Restraints:

6. Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Global Market Analysis

6.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Revenue (US$ Million), 2021–2031

6.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast Analysis

7. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis – by Drug Class

7.1 Non-Selective NSAIDs

7.1.1 Overview

7.1.2 Non-Selective NSAIDs: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

7.2 COX-2 Selective NSAIDs

7.2.1 Overview

7.2.2 COX-2 Selective NSAIDs: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

8. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis – by Route of Administration

8.1 Oral

8.1.1 Overview

8.1.2 Oral: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

8.2 Injectable

8.2.1 Overview

8.2.2 Injectable: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

8.3 Topical

8.3.1 Overview

8.3.2 Topical: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

9. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis – by Indication

9.1 Arthritis

9.1.1 Overview

9.1.2 Arthritis: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

9.2 Migraine

9.2.1 Overview

9.2.2 Migraine: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

9.3 Ophthalmic Diseases

9.3.1 Overview

9.3.2 Ophthalmic Diseases: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

9.4 Others

9.4.1 Overview

9.4.2 Others: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

10. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis – by Distribution Channel

10.1 Hospital Pharmacies

10.1.1 Overview

10.1.2 Hospital Pharmacies: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

10.2 Retail Pharmacies

10.2.1 Overview

10.2.2 Retail Pharmacies: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

10.3 Online Channels

10.3.1 Overview

10.3.2 Online Channels: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

11. Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Geographical Analysis

11.1 Overview

11.2 North America

11.2.1 North America Non-Steroidal Anti-inflammatory Drugs (NSAID) Market Overview

11.2.2 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2031 (US$ Million)

11.2.3 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.2.3.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Drug Class

11.2.4 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.2.4.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Route of Administration

11.2.5 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.2.5.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Indication

11.2.6 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.2.6.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Distribution Channel

11.2.7 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Country

11.2.7.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Country

11.2.7.2 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.2.7.2.1 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.2.7.2.2 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.2.7.2.3 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.2.7.2.4 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.2.7.3 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.2.7.3.1 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.2.7.3.2 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.2.7.3.3 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.2.7.3.4 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.2.7.4 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.2.7.4.1 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.2.7.4.2 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.2.7.4.3 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.2.7.4.4 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.3 Europe

11.3.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview

11.3.2 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2031 (US$ Million)

11.3.3 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.3.3.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Drug Class

11.3.4 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.3.4.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Route of Administration

11.3.5 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.3.5.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Indication

11.3.6 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.3.6.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Distribution Channel

11.3.7 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Country

11.3.7.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Country

11.3.7.2 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.3.7.2.1 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.3.7.2.2 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.3.7.2.3 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.3.7.2.4 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.3.7.3 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.3.7.3.1 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.3.7.3.2 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.3.7.3.3 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.3.7.3.4 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.3.7.4 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.3.7.4.1 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.3.7.4.2 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.3.7.4.3 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.3.7.4.4 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.3.7.5 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.3.7.5.1 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.3.7.5.2 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.3.7.5.3 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.3.7.5.4 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.3.7.6 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.3.7.6.1 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.3.7.6.2 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.3.7.6.3 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.3.7.6.4 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.3.7.7 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.3.7.7.1 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.3.7.7.2 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.3.7.7.3 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.3.7.7.4 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.4 Asia Pacific

11.4.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview

11.4.2 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2031 (US$ Million)

11.4.3 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.4.3.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Drug Class

11.4.4 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.4.4.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Route of Administration

11.4.5 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.4.5.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Indication

11.4.6 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.4.6.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Distribution Channel

11.4.7 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Country

11.4.7.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Country

11.4.7.2 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.4.7.2.1 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.4.7.2.2 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.4.7.2.3 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.4.7.2.4 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.4.7.3 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.4.7.3.1 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.4.7.3.2 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.4.7.3.3 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.4.7.3.4 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.4.7.4 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.4.7.4.1 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.4.7.4.2 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.4.7.4.3 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.4.7.4.4 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.4.7.5 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.4.7.5.1 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.4.7.5.2 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.4.7.5.3 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.4.7.5.4 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.4.7.6 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.4.7.6.1 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.4.7.6.2 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.4.7.6.3 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.4.7.6.4 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.4.7.7 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.4.7.7.1 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.4.7.7.2 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.4.7.7.3 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.4.7.7.4 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.5 Middle East and Africa

11.5.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview

11.5.2 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2031 (US$ Million)

11.5.3 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.5.3.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Drug Class

11.5.4 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.5.4.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Route of Administration

11.5.5 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.5.5.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Indication

11.5.6 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.5.6.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Distribution Channel

11.5.7 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Country

11.5.7.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Country

11.5.7.2 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.5.7.2.1 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.5.7.2.2 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.5.7.2.3 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.5.7.2.4 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.5.7.3 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.5.7.3.1 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.5.7.3.2 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.5.7.3.3 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.5.7.3.4 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.5.7.4 South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.5.7.4.1 South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.5.7.4.2 South Africa: Non-steroidal Anti-inflmatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.5.7.4.3 South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.5.7.4.4 South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.5.7.5 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.5.7.5.1 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.5.7.5.2 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.5.7.5.3 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.5.7.5.4 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.6 South and Central America

11.6.1 South and Central America Non-Steroidal Anti-inflammatory Drugs (NSAID) Market Overview

11.6.2 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2031 (US$ Million)

11.6.3 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.6.3.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Drug Class

11.6.4 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.6.4.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Route of Administration

11.6.5 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.6.5.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Indication

11.6.6 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.6.6.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Distribution Channel

11.6.7 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Country

11.6.7.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast Analysis – by Country

11.6.7.2 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.6.7.2.1 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.6.7.2.2 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.6.7.2.3 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.6.7.2.4 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.6.7.3 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.6.7.3.1 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.6.7.3.2 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.6.7.3.3 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.6.7.3.4 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

11.6.7.4 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.6.7.4.1 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class

11.6.7.4.2 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration

11.6.7.4.3 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication

11.6.7.4.4 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players

12.2 Company Market Share Analysis, 2024

13. Industry Landscape

13.1 Expansion

13.2 New Product Development

13.3 Other Business Strategies

14. Company Profiles

14.1 Pfizer Inc

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Bayer AG

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Dr. Reddy's Laboratories Ltd

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Glenmark Pharmaceuticals Ltd

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Sun Pharmaceutical Industries Ltd

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Novartis AG

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Hikma Pharmaceuticals Plc

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Boehringer Ingelheim International GmbH

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Viatris Inc

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Haleon Plc

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 Glossary of Terms

15.2 About The Insight Partners

List of Tables

Table 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segmentation

Table 2. Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million)

Table 3. Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million)

Table 4. Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 5. Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 6. Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 7. Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 8. Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 9. Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 10. Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 11. Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 12. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 13. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 14. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 15. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 16. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 17. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 18. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 19. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 20. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Country

Table 21. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country

Table 22. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 23. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 24. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 25. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 26. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 27. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 28. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 29. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 30. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 31. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 32. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 33. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 34. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 35. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 36. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 37. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 38. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 39. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 40. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 41. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 42. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 43. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 44. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 45. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 46. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 47. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 48. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 49. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 50. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 51. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 52. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 53. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 54. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Country

Table 55. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country

Table 56. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 57. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 58. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 59. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 60. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 61. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 62. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 63. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 64. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 65. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 66. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 67. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 68. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 69. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 70. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 71. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 72. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 73. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 74. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 75. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 76. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 77. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 78. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 79. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 80. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 81. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 82. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 83. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 84. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 85. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 86. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 87. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 88. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 89. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 90. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 91. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 92. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 93. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 94. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 95. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 96. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 97. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 98. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 99. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 100. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 101. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 102. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 103. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 104. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 105. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 106. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 107. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 108. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 109. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 110. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 111. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 112. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Country

Table 113. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country

Table 114. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 115. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 116. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 117. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 118. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 119. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 120. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 121. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 122. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 123. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 124. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 125. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 126. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 127. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 128. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 129. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 130. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 131. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 132. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 133. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 134. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 135. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 136. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 137. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 138. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 139. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 140. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 141. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 142. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 143. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 144. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 145. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 146. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 147. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 148. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 149. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 150. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 151. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 152. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 153. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 154. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 155. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 156. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 157. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 158. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 159. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 160. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 161. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 162. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 163. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 164. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 165. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 166. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 167. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 168. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 169. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 170. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Country

Table 171. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country

Table 172. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 173. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 174. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 175. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 176. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 177. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 178. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 179. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 180. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 181. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 182. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 183. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 184. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 185. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 186. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 187. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 188. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 189. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 190. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 191. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 192. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 193. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 194. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 195. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 196. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 197. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 198. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 199. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 200. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 201. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 202. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 203. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 204. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 205. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 206. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 207. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 208. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 209. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 210. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 211. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 212. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Country

Table 213. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country

Table 214. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 215. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 216. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 217. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 218. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 219. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 220. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 221. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 222. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 223. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 224. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 225. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 226. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 227. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 228. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 229. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 230. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Drug Class

Table 231. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Drug Class

Table 232. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Route of Administration

Table 233. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Route of Administration

Table 234. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 235. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 236. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 237. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 238. Heat Map Analysis by Key Players

Table 239. Glossary of Terms, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market

List of Figures

Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segmentation, by Geography

Figure 2. PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Revenue (US$ Million), 2021–2031

Figure 5. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (%) – by Drug Class (2024 and 2031)

Figure 6. Non-Selective NSAIDs: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 7. COX-2 Selective NSAIDs: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (%) – by Route of Administration (2024 and 2031)

Figure 9. Oral: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10. Injectable: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 11. Topical: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (%) – by Indication (2024 and 2031)

Figure 13. Arthritis: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 14. Migraine: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15. Ophthalmic Diseases: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 16. Others: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 17. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (%) – by Distribution Channel (2024 and 2031)

Figure 18. Hospital Pharmacies: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 19. Retail Pharmacies: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 20. Online Channels: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 21. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown by Region, 2024 and 2031 (%)

Figure 22. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2031 (US$ Million)

Figure 23. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class (2024 and 2031)

Figure 24. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration (2024 and 2031)

Figure 25. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication (2024 and 2031)

Figure 26. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel (2024 and 2031)

Figure 27. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 28. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 29. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 30. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 31. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2031 (US$ Million)

Figure 32. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class (2024 and 2031)

Figure 33. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration (2024 and 2031)

Figure 34. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication (2024 and 2031)

Figure 35. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel (2024 and 2031)

Figure 36. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 37. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 38. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 39. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 40. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 41. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 42. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 43. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2031 (US$ Million)

Figure 44. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class (2024 and 2031)

Figure 45. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration (2024 and 2031)

Figure 46. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication (2024 and 2031)

Figure 47. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel (2024 and 2031)

Figure 48. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 49. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 50. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 51. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 52. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 53. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 54. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 55. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2031 (US$ Million)

Figure 56. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class (2024 and 2031)

Figure 57. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration (2024 and 2031)

Figure 58. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication (2024 and 2031)

Figure 59. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel (2024 and 2031)

Figure 60. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 61. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 62. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 63. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 64. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 65. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue, 2021–2031 (US$ Million)

Figure 66. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class (2024 and 2031)

Figure 67. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration (2024 and 2031)

Figure 68. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication (2024 and 2031)

Figure 69. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel (2024 and 2031)

Figure 70. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 71. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 72. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 73. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 74. Company Market Share Analysis, 2024

The List of Companies - Non-steroidal Anti-inflammatory Drugs (NSAID) Market

Pfizer
Bayer AG
Glenmark Pharmaceuticals Ltd.
Dr. Reddy's Laboratories Ltd
Boehringer Ingelheim International GmbH
Haleon plc
Sun Pharmaceutical Industries Ltd
Novartis AG
Hikma Pharmaceuticals
Viatris Inc.
Teva Pharmaceutical Industries
Mylan
Aurobindo Pharma
Actavis
Wuxi AppTec
Zhejiang NHU
Johnson & Johnson (McNeil)
Sanofi
Reckitt Benckiser Group
Horizon Therapeutics
Assertio Holdings
Perrigo Company
AbbVie
Endo International
Orion Corporation
Strides Pharma Science Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
Validates and strengthens in-house secondary research findings
Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

Industry participants: VPs, business development managers, market intelligence managers and national sales managers
Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Nonsteroidal Anti-inflammatory Drugs (NSAID) Market Report 2025-2031: Key Players & Insights

Nonsteroidal Anti-inflammatory Drugs (NSAID) Market Analysis

Nonsteroidal Anti-inflammatory Drugs (NSAID) Market Overview

Customize Research To Suit Your Requirement

Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market: Strategic Insights

Have a question?

Market Drivers:

Expanding Preference for NSAIDs as Non-Opioid Pain Management:

Increasing Prevalence Of Chronic and Inflammatory Diseases:

Rising Aging Population:

Market Opportunities:

Expansion in Emerging Economies:

Rising Strategic Initiatives:

Nonsteroidal Anti-inflammatory Drugs (NSAID) Market Report Segmentation Analysis

By Drug Class:

Nonselective NSAIDs:

COX-2 Selective NSAIDs:

By Route Of Administration:

Oral:

Injectable:

Topical:

By Route Of Administration:

By Distribution Channel:

By Geography:

Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Report ScopeNonsteroidal Anti-inflammatory Drugs (NSAID) Market Share Analysis by Geography

1. North America

Market Share:

Key Drivers:

Trends:

2. Europe

Market Share:

Key Drivers:

Trends:

3. Asia Pacific

Market Share:

Key Drivers:

Trends:

4. South and Central America

Market Share:

Key Drivers:

Trends:

5. Middle East and Africa

Market Share:

Key Drivers:

Trends:

Nonsteroidal Anti-inflammatory Drugs (NSAID) Market Players Density: Understanding Its Impact on Business Dynamics

High Market Density and Competition

Opportunities and Strategic Moves

Major Companies operating in the Nonsteroidal Anti-inflammatory Drugs (NSAID) Market are:

Disclaimer: The companies listed above are not ranked in any particular order.

Nonsteroidal Anti-inflammatory Drugs (NSAID) Market News and Recent Developments

Boehringer Ingelheim BioXcellence is expanding its service portfolio in China

Hikma Pharmaceuticals PLC (Hikma) launched Indomethacin suppositories in the US.

Nonsteroidal Anti-inflammatory Drugs (NSAID) Market Report Coverage and Deliverables

Report Coverage

Segment Covered

Regional Scope

Country Scope

Frequently Asked Questions

1. Introduction

2. Executive Summary

3. Research Methodology

4. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Landscape

5. Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Key Market Dynamics

6. Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Global Market Analysis

7. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis – by Drug Class

8. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis – by Route of Administration

9. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis – by Indication

10. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis – by Distribution Channel

11. Non-steroidal Anti-inflammatory Drugs (NSAID) Market – Geographical Analysis

12. Competitive Landscape

13. Industry Landscape

14. Company Profiles

15. Appendix

List of Tables

List of Figures

Wheelchair and Mobility Aids Market

Cystoscopy and Ureteroscopy Market

Cancer Drugs Market

Walking Aids Market